MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes

Implications of Low-Titer MOG Antibodies

(2022) Michael Levy et al.   Multiple Sclerosis and Related Disorders

Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS

(2021) Yunyun Duan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing

(2021) Elia Sechi et al.   JAMA Neurology

MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response

(2021) Kathryn Pellerin et al.   BRAIN

Myelin-oligodendrocyte glycoprotein antibody-associated disease

(2021) Romain Marignier et al.   LANCET NEUROLOGY

Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF

(2021) Young Nam Kwon et al.   Neurology-Neuroimmunology & Neuroinflammation

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody

(2020) Romana Höftberger et al.   ACTA NEUROPATHOLOGICA

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

(2020) Thaís Armangue et al.   LANCET NEUROLOGY

Unilateral Leptomeningeal Enhancement in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G–Associated Disease

(2020) Adrian Budhram et al.   JAMA Neurology

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study

(2020) Yoshiki Takai et al.   BRAIN

Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies

(2020) Andreas Wegener-Panzer et al.   Neurology-Neuroimmunology & Neuroinflammation

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

(2020) John J. Chen et al.   NEUROLOGY

Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

(2020) Alvaro Cobo‐Calvo et al.   ANNALS OF NEUROLOGY

Brain structural and functional alterations in MOG antibody disease

(2020) Zhizheng Zhuo et al.   Multiple Sclerosis Journal

MOG-IgG1 and co-existence of neuronal autoantibodies

(2020) Amy Kunchok et al.   Multiple Sclerosis Journal

Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis

(2020) Woo-Jin Lee et al.   Neurotherapeutics

MOG antibody–associated encephalomyelitis/encephalitis

(2019) Sara Salama et al.   Multiple Sclerosis Journal

CSF1R antagonism limits local restimulation of antiviral CD8+ T cells during viral encephalitis

(2019) Kristen E. Funk et al.   Journal of Neuroinflammation

Development of the clinical assessment scale in autoimmune encephalitis

(2019) Jung-Ah Lim et al.   ANNALS OF NEUROLOGY

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults

(2019) CL de Mol et al.   Multiple Sclerosis Journal

Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome

(2019) A. Budhram et al.   JOURNAL OF NEUROLOGY

Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: A case report

(2019) Hirokazu Uchigami et al.   Multiple Sclerosis and Related Disorders

Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein

(2018) Melania Spadaro et al.   ANNALS OF NEUROLOGY

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

(2018) Alvaro Cobo-Calvo et al.   NEUROLOGY

Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China

(2018) L. Wang et al.   EUROPEAN JOURNAL OF NEUROLOGY

Tocilizumab treatment for new onset refractory status epilepticus

(2018) Jin-Sun Jun et al.   ANNALS OF NEUROLOGY

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

(2018) Markus Reindl et al.   Nature Reviews Neurology

Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies

(2017) Juichi Fujimori et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases

(2017) Jae-Won Hyun et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

(2017) Sudarshini Ramanathan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies

(2017) Lei Zhou et al.   Multiple Sclerosis and Related Disorders

A clinical approach to diagnosis of autoimmune encephalitis

(2016) Francesc Graus et al.   LANCET NEUROLOGY

Microglial brain region−dependent diversity and selective regional sensitivities to aging

(2016) Kathleen Grabert et al.   NATURE NEUROSCIENCE

Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort

(2016) Woo-Jin Lee et al.   NEUROLOGY

Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study

(2016) Woo-Jin Lee et al.   Neurotherapeutics

VGKC-complex/LGI1-antibody encephalitis: Clinical manifestations and response to immunotherapy

(2013) Yong-Won Shin et al.   JOURNAL OF NEUROIMMUNOLOGY

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

(2013) Maarten J Titulaer et al.   LANCET NEUROLOGY

Microglia Modulate Hippocampal Neural Precursor Activity in Response to Exercise and Aging

(2012) J. Vukovic et al.   JOURNAL OF NEUROSCIENCE